Dutch Acute HCV in HIV Study (DAHHS-2): Grazoprevir/Elbasvir for Acute HCV
NCT02600325
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
80
Enrollment
OTHER
Sponsor class
Conditions
Acute Hepatitis C
Human Immunodeficiency Virus
Hepatitis C
Interventions
DRUG:
Grazoprevir/Elbasvir 100mg/50mg
Sponsor
Erasmus Medical Center